{"id":"https://openalex.org/W2047200439","doi":"https://doi.org/10.1089/cap.2009.0122","title":"A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder","display_name":"A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-01","ids":{"openalex":"https://openalex.org/W2047200439","doi":"https://doi.org/10.1089/cap.2009.0122","mag":"2047200439","pmid":"https://pubmed.ncbi.nlm.nih.gov/20973707"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2009.0122","doi":"https://doi.org/10.1089/cap.2009.0122","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2009.0122","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2047200439"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042787535","display_name":"Robert L. Findling","orcid":"https://orcid.org/0000-0002-7654-5782","observed_orcids":["https://orcid.org/0000-0002-7654-5782"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert L. Findling","raw_affiliation_strings":["University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio","University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]},{"raw_affiliation_string":"University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086904752","display_name":"Alain Katic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103539","display_name":"Claghorn Lesem Research Clinic","ror":"https://ror.org/013sb0f58","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210103539"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alain Katic","raw_affiliation_strings":["Claghorn Lesem Research Clinic Ltd., Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Claghorn Lesem Research Clinic Ltd., Houston, Texas","institution_ids":["https://openalex.org/I4210103539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066347853","display_name":"Richard L. Rubin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Rubin","raw_affiliation_strings":["The Vermont Clinical Center and Dartmouth Medical College, Burlington, Vermont"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Vermont Clinical Center and Dartmouth Medical College, Burlington, Vermont","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017996915","display_name":"Eliot Moon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eliot Moon","raw_affiliation_strings":["Elite Clinical Trials, Inc., Temecula, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elite Clinical Trials, Inc., Temecula, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109098321","display_name":"Richard H. Civil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Civil","raw_affiliation_strings":["Shire Development, Inc., Wayne, Pennsylvania. Dr. Li is now at Cereta, Inc., Oakland, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development, Inc., Wayne, Pennsylvania. Dr. Li is now at Cereta, Inc., Oakland, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100326031","display_name":"Yunfeng Li","orcid":"https://orcid.org/0000-0003-2659-8074","observed_orcids":["https://orcid.org/0000-0003-2659-8074"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yunfeng Li","raw_affiliation_strings":["Shire Development, Inc., Wayne, Pennsylvania. Dr. Li is now at Cereta, Inc., Oakland, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development, Inc., Wayne, Pennsylvania. Dr. Li is now at Cereta, Inc., Oakland, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042787535"],"corresponding_institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I58956616"],"apc_list":null,"apc_paid":null,"fwci":1.2043,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.76503212,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"20","issue":"5","first_page":"365","last_page":"375"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9670000076293945},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.9850000143051147},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7770000100135803},{"id":"https://openalex.org/keywords/skin-tolerability","display_name":"skin tolerability","score":0.8009999990463257},{"id":"https://openalex.org/keywords/skin-reactions","display_name":"skin reactions","score":0.7350000143051147},{"id":"https://openalex.org/keywords/adhd-rating-scale-iv","display_name":"ADHD Rating Scale-IV","score":0.7739999890327454},{"id":"https://openalex.org/keywords/long-term-treatment-effectiveness","display_name":"long-term treatment effectiveness","score":0.5429999828338623},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9586417078971863},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7876298427581787},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.777916669845581},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6491169333457947},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5948792695999146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4964171051979065},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.4237539768218994},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41526955366134644},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34969431161880493},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.32869040966033936},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2863132357597351},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26747843623161316},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.09229382872581482}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001066","descriptor_name":"Appetite","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.2009.0122","doi":"https://doi.org/10.1089/cap.2009.0122","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2009.0122","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:20973707","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20973707","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W115795496","https://openalex.org/W367527110","https://openalex.org/W629283852","https://openalex.org/W1965229373","https://openalex.org/W1965518468","https://openalex.org/W1965946834","https://openalex.org/W1973510512","https://openalex.org/W1983282129","https://openalex.org/W1998857835","https://openalex.org/W2013372650","https://openalex.org/W2018912237","https://openalex.org/W2025830177","https://openalex.org/W2043888513","https://openalex.org/W2049884384","https://openalex.org/W2056663519","https://openalex.org/W2059930343","https://openalex.org/W2066789625","https://openalex.org/W2069755605","https://openalex.org/W2076517504","https://openalex.org/W2087925710","https://openalex.org/W2094244099","https://openalex.org/W2113651750","https://openalex.org/W2114290463","https://openalex.org/W2119458175","https://openalex.org/W2148818658","https://openalex.org/W2167062019","https://openalex.org/W2171074660","https://openalex.org/W2467079106","https://openalex.org/W2490103761","https://openalex.org/W2949419834","https://openalex.org/W3196369884"],"related_works":["https://openalex.org/W2069755605","https://openalex.org/W2467079106","https://openalex.org/W1480841980","https://openalex.org/W2056663519","https://openalex.org/W2034857976","https://openalex.org/W2110549907","https://openalex.org/W2001101807","https://openalex.org/W1965229373","https://openalex.org/W2083107510","https://openalex.org/W1965518468"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,89,118],"aim":[2],"of":[3,13,36,83,91,121,149,157],"this":[4,152],"study":[5,35,114,137,156],"was":[6,30,73,106,128,164],"to":[7,59,116,139,176],"evaluate":[8],"the":[9,14,76,101,113,159],"tolerability":[10,172],"and":[11,54,69,100,170,184],"effectiveness":[12],"methylphenidate":[15],"transdermal":[16],"system":[17],"(MTS)":[18],"over":[19,51],"6":[20],"months":[21],"in":[22,98,131,182,189,192],"adolescents":[23],"with":[24,41,46,75,179],"attention-deficit/hyperactivity":[25],"disorder":[26],"(ADHD).":[27],"METHODS:":[28],"This":[29],"an":[31],"industry-sponsored,":[32],"30-center,":[33],"open-label":[34,154],"subjects":[37,85,111,150],"aged":[38],"13-17":[39],"years":[40],"ADHD.":[42],"Subjects":[43],"were":[44,94,174],"dose-optimized":[45],"MTS":[47,87,180,186],"(10-30":[48],"mg/9":[49],"hours)":[50],"5":[52,60],"weeks":[53],"then":[55],"dose-maintained":[56],"for":[57,162],"up":[58],"months.":[61],"Tolerability":[62],"evaluations":[63],"included":[64],"treatment-emergent":[65],"adverse":[66],"events":[67],"(TEAEs)":[68],"dermal":[70],"responses.":[71],"Effectiveness":[72],"assessed":[74],"ADHD-Rating":[77],"Scale-IV":[78],"(ADHD-RS-IV).":[79],"RESULTS:":[80],"A":[81],"total":[82,134],"162":[84],"received":[86],"treatment.":[88],"majority":[90,119],"TEAEs":[92,169],"(>99%)":[93],"mild":[95,125],"or":[96],"moderate":[97],"intensity,":[99],"most":[102],"frequently":[103],"reported":[104],"TEAE":[105],"decreased":[107],"appetite":[108],"(15.4%).":[109],"Thirteen":[110],"discontinued":[112],"due":[115],"TEAEs.":[117],"(93.6%)":[120],"dermatologic":[122],"reactions":[123],"indicated":[124],"erythema.":[126],"There":[127],"significant":[129],"improvement":[130],"mean":[132],"ADHD-RS-IV":[133],"scores":[135],"from":[136],"entry":[138],"end":[140],"point":[141],"(p<0.001).":[142],"CONCLUSION:":[143],"Slightly":[144],"more":[145],"than":[146],"half":[147],"(54.0%)":[148],"completed":[151],"6-month,":[153],"extension":[155],"MTS;":[158],"primary":[160],"reason":[161],"discontinuation":[163],"withdrawn":[165],"consent":[166],"(36.0%).":[167],"Reported":[168],"skin":[171],"findings":[173],"similar":[175],"those":[177],"observed":[178],"use":[181],"children":[183],"adolescents.":[185],"treatment":[187],"resulted":[188],"a":[190],"decrease":[191],"ADHD":[193],"symptoms":[194],"as":[195],"rated":[196],"by":[197],"clinicians.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2047200439","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
